Camille-Melchior Gibert
Camille-Melchior Gibert (1797–1866) was a French dermatologist who is best known for describing a skin disease, now known as Gibert's disease or pityriasis rosea. Gibert was a prominent figure in the field of dermatology in the 19th century, and his work significantly contributed to the understanding and treatment of skin diseases during that time.
Biography[edit | edit source]
Camille-Melchior Gibert was born in 1797 in France. He pursued his medical education with a focus on dermatology, a field that was still in its infancy at the time. Throughout his career, Gibert was dedicated to the study of skin diseases, and he was particularly interested in the clinical observation and description of various dermatological conditions.
Contributions to Dermatology[edit | edit source]
Gibert's most notable contribution to dermatology was his description of a specific skin condition characterized by the appearance of a herald patch, followed by a widespread rash. He first described this condition in the mid-19th century, and it was later named Gibert's disease or pityriasis rosea. This condition is now recognized as a common skin disorder that typically resolves without treatment within several weeks to months.
In addition to his work on pityriasis rosea, Gibert was involved in the study and treatment of other skin diseases, including syphilis and eczema. He advocated for the use of mercury in the treatment of syphilis, which was a common practice at the time.
Legacy[edit | edit source]
Camille-Melchior Gibert's contributions to dermatology are still recognized today. His description of pityriasis rosea remains a fundamental part of dermatological literature and has helped to shape the understanding of this and other skin conditions. Gibert's dedication to the clinical observation and detailed description of skin diseases laid the groundwork for future research and advancements in dermatology.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD